聚酸盐降解生物治疗中的酶 - 目前的状况和未来的前景
Marius Nicolaus Felix1, Thomas Waerner1, Daniel Lakatos2
1Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co., KG, Innovation Unit, Biberach an der Riss, Germany.
生物疗法中的酶可以降解聚酸盐 (PS),影响药物的稳定性并导致颗粒. 先进的分析和缓解策略对于管理药物制造中的酶性聚酸盐降解至关重要.
科学领域:
- 生物制药制造业 生物制药制造业
- 蛋白质稳定 蛋白质稳定
- 分析化学 分析化学
背景情况:
- 聚酸盐 (PS) 20和80是生物治疗稳定性的关键表面活性剂.
- 宿主细胞蛋白 (HCP) 酶性降解PS可以释放自由脂肪酸,影响药物产品的质量.
- 这种降解可能导致颗粒形成和表面活性剂功能受损.
研究的目的:
- 审查参与哺乳动物生物技术过程中聚酸盐降解的酶.
- 讨论用于合格和量化PS降解酶的先进分析方法.
- 探索酶降解对药物产品质量属性和缓解策略的影响.
主要方法:
- 对参与聚酸盐降解的酶的文献综述.
- 讨论基于质谱的分析方法与HCP丰富.
- 酶活性与观察到的聚酸盐降解的相关性以及对药物产品质量的影响.
主要成果:
- 确定了负责酶性聚酸盐降解的关键酶.
- 强调了微量HP,酶活性和PS降解之间的联系.
- 证明了对药物产品质量的影响,包括颗粒形成和脂肪酸可溶性问题.
结论:
- 酶性聚酸盐降解对生物制药药品质量构成重大风险.
- 先进的分析技术对于识别和量化PS降解酶至关重要.
- 缓解策略,包括HCP淘汰细胞系,对于防止药物制造过程中的降解至关重要.
更多相关视频
10:58Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
Published on: September 6, 2012
15:33Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
Published on: October 29, 2013
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drug Biotransformation: Overview
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Lysosomal Hydrolases
Types of Step-Growth Polymers: Polyesters
Polyesters are commonly prepared from terephthalic acid and ethylene glycol; the crude product is known as poly(ethylene terephthalate) or PET. However, polyesters are synthesized industrially by transesterification of dimethyl terephthalate with ethylene glycol at 150 °C. The two reactants and the...
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
